Arcadia Biosciences (RKDA) Gross Margin (2014 - 2025)

Arcadia Biosciences' Gross Margin history runs 12 years deep, the most recent figure standing at 21.31% for Q4 2025.

• Quarterly Gross Margin fell 1068.0% year-over-year to 21.31% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 36.21% (down 507.0% YoY) and the FY2025 annual result came in at 36.23%, down 504.0% from the prior year.
• Gross Margin was 21.31% for Q4 2025 at Arcadia Biosciences, down from 32.1% in the prior quarter.
• Across five years, Gross Margin topped out at 115.49% in Q4 2022 and bottomed at 7.39% in Q1 2022.
• A 5-year average of 38.81% and a median of 34.92% in 2023 frame the typical range for Gross Margin.
• Annual changes were most pronounced in 2021 — Gross Margin jumped 53006 bps — and 2022, when it plunged 8916 bps.
• Arcadia Biosciences' Gross Margin stood at 12.7% in 2021, then surged by 809 bps to 115.49% in 2022, then plunged by 33 bps to 77.09% in 2023, then sank by 59 bps to 31.99% in 2024, then slumped by 33 bps to 21.31% in 2025.
• Business Quant data shows RKDA's Gross Margin at 21.31% in Q4 2025, 32.1% in Q3 2025, and 43.37% in Q2 2025.